Epstein Secrets

say that there was not a new tone of unity in Washington simply because of her nomination." In addition, the Wall Street Journal (2/22, Restuccia, Collins, Subscription Publication, 8.41M) reports Psaki "said White House officials spoke to senators of both parties about the nomination over the weekend

ook, 3.57M) reports that the three senators "criticized Tanden's temperament, saying her past habit of attacking Republicans on Twitter - including Collins, whom she once called 'the worst' - left her unsuited for the budget job." Bloomberg adds that Collins "also criticized Tanden for deleting more tha

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

been transfused with the treatment, called EFTA00136347 convalescent plasma, under an expanded access program" sponsored by the FDA. NIH Director Collins said, "The way Americans are doing this is truly inspiring." Bloomberg <https://vvwvv.bloomberg.corn/news/articles/2020-07-30/trump-urges-americans

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

Harris "thank[ed] the doctors and scientists for their lifesaving work and urg[ed] Americans to get the vaccine when they can." CNN (1/26, Zeleny, Collins, 89.21M) reports on its website that "several hundred White House employees had been vaccinated for Covid-19 as of Tuesday, two Biden administratio

uccia, Subscription Publication, 8.41M), Politico (1/26, Cancryn, Roubein, 6.73M), and The Hill (1/26, Sullivan, Samuels, 5.69M) also have reports. Johnson & Johnson Expects To Report Vaccine Data Next Week. Reuters (1/26, Mishra, O'Donnell) reports that on Tuesday, Johnson & Johnson "said it expected to report

00 people "have been transfused with the treatment, called convalescent plasma, under an expanded access program" sponsored by the FDA. NIH Director Collins said, "The way Americans are doing this is truly inspiring." Bloomberg (7/30, Edney, Jacobs, 4.73M) quotes HHS Secretary Azar as saying, "This is g

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

s Warn Vaccine Hesitancy Poses Threat To Herd Immunity. The Wall Street Journal (4/25, Corse, Subscription Publication, 8.41M) reports NIH Director Collins and NIAID Director Fauci on Sunday warned that vaccine hesitancy could prevent the country from reaching herd immunity and stopping the spread of CO

ew surge." Although the Times adds "experts aren't sure why vaccination rates have begun falling, or whether vaccine hesitancy, an issue before the Johnson & Johnson pause, is entirely to blame," Lilia Luciano reported on the CBS Weekend NewsVi (4/25, lead story, 2:30, Duncan, 1.24M) that a new CBS News poll "fin

ursday "said...that the bill's passage 'sends a clear and unmistakable message of solidarity' to the Asian American and Pacific Islander community. Collins said it 'affirms our commitment to stand with' them against hate crimes." The New York Daily News (4/22, Sommerfeldt, 2.51M) reports that Schumer "

ine Use. The Washington Post (4/22, Al, McGinley, Sun, 10.52M) reports, "Federal health authorities are leaning toward recommending that use of the Johnson & Johnson coronavirus vaccine resume, possibly as soon as this weekend - a move that would include a new warning about a rare complication involving blood cl

00 people "have been transfused with the treatment, called convalescent plasma, under an expanded access program" sponsored by the FDA. NIH Director Collins said, "The way Americans are doing this is truly inspiring." Bloomberg (7/30, Edney, Jacobs, 4.73M) quotes HHS Secretary Azar as saying, "This is g

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake